Tompkins Financial’s NEOPHOTONICS CORP NPTN Stock Holding History

Tompkins Financial’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-47	Closed	–	–	562
2020 Q4	$0	Buy	+47	New	+$364	﹤0.01%	570

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Tompkins Financial's NPTN Position: Q1 2021 in Review

Tompkins Financial sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 47 shares.

Tompkins Financial first reported a position in NPTN in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

Tompkins Financial reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
Tompkins Financial sold 47 NEOPHOTONICS CORP shares in Q1 2021.
Tompkins Financial first reported a position in NEOPHOTONICS CORP in Q4 2020 and held it in 1 quarter.
Tompkins Financial's NEOPHOTONICS CORP position peaked at $0 in Q4 2020.
147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Tompkins Financial's 13F filing for Q1 2021, filed 9 Jun 2021.